The mechanism of drug interactions of a selected antiarrhythmic drug with metformin, in different animal models

The mechanism of drug interactions of a selected antiarrhythmic drug with metformin, in different animal models

ABSTRACT This study was carried out to understand the influence of a selected antiarrhythmic drug on the pharmacodynamics and pharmacokinetics of an antidiabetic drug in animal models. Pharmacodynamic and pharmacokinetic responses were determined by measurements of blood glucose and serum insulin an...

Full description

Bibliographic Details
Main Authors:	Kayamkani Abedulla Khan, Sreemantula Satyanarayana, Kilari Eswar Kumar
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2018-01-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Disopyramide/pharmacokinetic interactions/pharmacodynamic Metformin/ pharmacokinetic interactions/pharmacodynamic Drug Interactions Hypoglycaemia Diabetes mellitus.
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000400601&lng=en&tlng=en

Similar Items

Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia
by: Rong-Rong Li, et al.
Published: (2019-05-01)

Interactions of herbs with conventional drugs
by: F Khalighi Sigaroodi, et al.
Published: (2003-06-01)

Polytherapy and drug interactions in elderly
by: Hima Bindu Gujjarlamudi
Published: (2016-01-01)

Implications of the use of hydroxychloroquine on cardioactive drugs
by: Soumitra Ghosh, et al.
Published: (2021-01-01)

Potential pharmacokinetic and pharmacodynamic herb-drug interactions of Andrographis paniculata (Burm. f.) and andrographolide: A systematic review
by: Elza Sundhani, et al.
Published: (2022-04-01)

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
by: Rhee SJ, et al.
Published: (2016-08-01)

The interactions between COVID-19 drugs and psychotropic agents
by: C. Hiemke
Published: (2021-04-01)

New Perspective for Drug–Drug Interaction in Perioperative Period
by: Abigail Silva, et al.
Published: (2023-07-01)

Real-World Analysis of Potential Pharmacokinetic and Pharmacodynamic Drug Interactions with Apixaban in Patients with Non-Valvular Atrial Fibrillation
by: Badreldin HA, et al.
Published: (2020-07-01)

Herb-drug interaction resources: The PHYDGI database
by: J. Perrot, et al.
Published: (2022-08-01)

Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects
by: Kim CH, et al.
Published: (2017-12-01)

Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
by: Hwang I, et al.
Published: (2020-10-01)

Editorial: Pharmacological interaction between drugs and medicinal plants, Volume II
by: Maria Eva González-Trujano, et al.
Published: (2024-01-01)

Achillea millefolium: Mechanism of action, pharmacokinetic, clinical drug-drug interactions and tolerability
by: Bahareh Farasati Far, et al.
Published: (2023-12-01)

Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
by: Lei Sun, et al.
Published: (2023-07-01)

Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications
by: Ramesh C. Gupta, et al.
Published: (2017-07-01)

Personalized Medicine for Classical Anesthesia Drugs and Cancer Progression
by: Bárbara Costa, et al.
Published: (2022-11-01)

Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
by: Marios Spanakis, et al.
Published: (2021-02-01)

Mechanisms and the clinical relevance of complex drug–drug interactions
by: Roberts AG, et al.
Published: (2018-09-01)

Pharmacokinetic and pharmacodynamic drug-drug interaction of Nomilin with atorvastatin in hyperlipidemic mice
by: Yan Ding, et al.
Published: (2023-11-01)

Pharmacokinetic and pharmacodynamic herb-drug interactions—part I. Herbal medicines of the central nervous system
by: Szilvia Czigle, et al.
Published: (2023-11-01)

The effect of OCT-2 inhibitor Daclatasvir on Metformin pharmacokinetics and pharmacodynamics at two dose levels: A Bayesian approach using Markov-Chain Monte Carlo simulations
by: Mohamed Raslan, et al.
Published: (2022-12-01)

Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions
by: Marina Barakat, et al.
Published: (2022-12-01)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
by: Raghunandan Reddy Kura, et al.
Published: (2018-05-01)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020-10-01)

Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin
by: Robert Dobbins, et al.
Published: (2021-06-01)

Drug Interactions of Metformin Involving Drug Transporter Proteins
by: Naina Mohamed Pakkir Maideen, et al.
Published: (2017-12-01)

Population pharmacokinetics and dosing simulations of imipenem in serious bacteraemia in immunocompromised patients with febrile neutropenia
by: Sutep Jaruratanasirikul, et al.
Published: (2015-02-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

The Impact of Diet and Exercise on Drug Responses
by: Ellen Niederberger, et al.
Published: (2021-07-01)

Revealing the dynamic landscape of drug-drug interactions through network analysis
by: Eugene Jeong, et al.
Published: (2023-10-01)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
by: Roganović Maša, et al.
Published: (2021-01-01)

Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats
by: Dong-Seok Lee, et al.
Published: (2018-04-01)

Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions
by: Kolli P, et al.
Published: (2023-12-01)

Model-Informed Drug Discovery and Development Strategy for the Rapid Development of Anti-Tuberculosis Drug Combinations
by: Rob C. van Wijk, et al.
Published: (2020-03-01)

Preparation of Nanocrystals for Insoluble Drugs by Top-Down Nanotechnology with Improved Solubility and Bioavailability
by: Xun Zhang, et al.
Published: (2020-02-01)

Study on consequences for interaction of myricetin with canagliflozin: A special attention to pharmacokinetics and pharmacodynamics of drug
by: Naga Raju Kandukoori, et al.
Published: (2023-01-01)

Pharmacokinetics of Chinese medicines: strategies and perspectives
by: Ru Yan, et al.
Published: (2018-05-01)

Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation
by: Pan Ma, et al.
Published: (2023-06-01)

Use of antiepileptic drugs in the elderly
by: W Muangpaisan
Published: (2005-08-01)